Navigation Links
Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection
Date:6/9/2009

Launch represents first available generic equivalent of Alkeran(R)

LAKE FOREST, Ill., and NEWTOWN, Pa., June 9 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC, announced today the FDA approval and launch of Melphalan Hydrochloride for Injection, the generic equivalent of Alkeran(R) from GlaxoSmithKline.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO)

Bioniche Pharma and Synerx Pharma entered into a definitive agreement whereby Synerx developed and secured the U.S. Food and Drug Administration's approval of Melphalan and Bioniche Pharma has the exclusive rights to market and distribute Melphalan in the United States.

"The launch of Melphalan represents Bioniche's introduction to the generic injectable oncology market and underscores our commitment to rapid and aggressive product line growth," said George Zorich, President, US Operations for Bioniche Pharma. "We are pleased to have partnered with Synerx and value their expertise in developing this specialty generic product to meet the needs of cancer patients."

Bioniche Pharma will commence shipment of Melphalan Hydrochloride for Injection immediately in cartons with one single-use vial containing melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL vial of sterile diluent.

About Bioniche Pharma:

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology and dermatology. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in February 2006 by RoundTable Heal
'/>"/>

SOURCE Bioniche Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bioniche Represented at House of Commons Sub-Committee on Food Safety
2. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
3. Bioniche Reports Fiscal 2009 Third Quarter
4. Bioniche Provides a Corporate Update
5. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
6. Bioniche Revolving Credit Facility Maturity Date Amended
7. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
8. Bioniche Warrants Expiration Date to be Extended
9. Bioniche Reports Fiscal 2009 Second Quarter
10. Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable
11. Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... The Cabin Chiang Mai, Asia’s leading inpatient addiction treatment ... – a free comprehensive aftercare service for clients ... wherever they live in the world. , The Cabin ... them maintain their recovery after successfully completing primary treatment ... programme. As a chronic disease, addicts in recovery are ...
(Date:7/14/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on Hospira Lactated Ringer’s and 5% ... 11, that one lot of Lactated Ringers and 5% ... Inc., is recalled due to mold contamination. The specific ... of fluid and electrolytes, with or without minimal carbohydrate ...
(Date:7/14/2014)... According to the Blood Pressure Solution book review recently ... a series of new information on high blood pressure ... can help readers understand more about blood pressure. The book ... methods to control hypertension naturally. , Blood ... penned by Ken Burge, a medical researcher and health consultant. ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 According to the Boost ... helpful book for women who want to learn how to increase ... This book consists of 7 chapters including:, , ... Grow? , Chapter 2 – How Natural Breast Enlargement ... Your Breasts Look Bigger , Chapter 4 – The ...
(Date:7/14/2014)... "Medical devices, tests, and treatments are critical ... is a star when it comes to innovations in ... working on amazing products and ideas that are our ... to Dale Kaye CEO of the Innovation Tri-Valley ... brilliant minds and businesses that are leading society into ...
Breaking Medicine News(10 mins):Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 2Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 3Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 2Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 3Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 3Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 3Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 3Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 4
... ... material testing, announced that via findings from their 3rd quarter "Packaging Quizzler" nearly half ... humidity should mimic the equivalent water content. , ... Minneapolis, MN (PRWEB) October 19, 2009 -- DDL, leader ...
... of thiopurines bears further study, researchers say , MONDAY, ... drugs to treat inflammatory bowel disease (IBD) increases the ... a new study. , IBD includes Crohn,s disease and ... immune system in order to maintain remission in IBD ...
... N.J. Oct. 19 America,s Toughest Trainer and Health ... is designed specifically for on-the-go fitness! Majesco Entertainment Company ... games for the mass market, and Interactive Game Group, ... for Nintendo DS(TM) will be available at retailers ...
... has been awarded special federal funding to support the ... Medicare Quality Improvement Organization (QIO) for the state of ... in a variety of settings. QIOs operate in all ... federal Centers for Medicare & Medicaid Services (CMS). , ...
... 19 As flu season is fast reaching its ... hold among workers, with more than 70 percent saying ... Now(SM) survey released today from ComPsych Corporation. Almost half ... and the touching of workplace surfaces in order to ...
... suggests a connection with lupus, rheumatoid arthritis , ... a link between women,s exposure to household insecticides -- ... disorders rheumatoid arthritis and lupus. , The scientist did ... and the illnesses, and it,s possible that the women ...
Cached Medicine News:Health News:DDL's 'Packaging Quizzler' Tests Medical Device Packaging Professionals' Knowledge on Appropriate Humidity Used for Accelerated Aging 2Health News:Drugs for Inflammatory Bowel Might Increase Cancer Risk 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 3Health News:IPRO Wins Federal Contract to Support Hospice Oversight 2Health News:New Flu Poll: Employees Avoid Each Other to Prevent Flu, Yet Almost One-Third Not Changing Behavior 2Health News:Household Insecticides May Be Linked to Autoimmune Diseases 2Health News:Household Insecticides May Be Linked to Autoimmune Diseases 3
(Date:7/14/2014)... 2014  Mylan Inc. (NASDAQ: MYL ) today ... Abbott (NYSE: ABT ) ... developed markets specialty and branded generics business ("the Assets") in ... will receive 105 million shares of the combined company worth ... on Friday, July 11, 2014, representing an approximately 21% ownership ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... Research and Markets  has announced the ... report to their offering. ... a hollow needle commonly used with a syringe to ... fluids from it. A hypodermic needle is used for ... cannot be ingested. Hypodermic needles are broadly classified into ...
Breaking Medicine Technology:Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... spine can happen for any number of reasons, whether it,s ... old age, or blunt injury. Unfortunately, people who have experienced ... back braces, reduced mobility, and elongated periods of pain and ... patients are able to restore proper function to the spine ...
... 17, 2011 Zen Holding Corp. (Symbol: ZNHL) today ... name change to Millennium HealthCare Inc.  The Company will ... change as well. About Zen Holding Corp. ... company that operates thru its wholly-owned subsidiaries Greenleaf Management ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Zen Holding Corp. Changes Name to Millennium HealthCare Inc. 2
... This microtome is the most convenient ... research and in industrial laboratories. Specimen rise ... setting from 0.5 to 12 microns in ... all MNL Freezing Stages.,Other Associated Products, ...
... The Starter Package is a ... laboratory. The package includes the Vibratome ... blocks, v-block adapter, specimen mounts w/1/2" ... for ease in all of your ...
... is a solid solution for ... package includes the Vibratome Plus, ... blocks, v-block adapter, specimen mounts ... stage assembly for ease in ...
... The Vibratome 1500 Sectioning System provides a ... animal, or plant tissues. The 1500 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
Medicine Products: